ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 364830 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 364830; 2) Community: the network communities that were significantly associated with the response to NSC 364830; 3) Molecule: the relationships between components within communities and NSC 364830; 4) MDR: the compounds that were significantly associated with the NSC 364830.

NSC Compound Enrichment Correlation
NSC 355644 Anthrapyrazole derivative 0.0171490505199913 0.54737458
NSC 622115 Null 0.0171490505199913 -0.087476519
NSC 681642 Camptothecin Derivative 0.0171490505199913 0.88605207
NSC 686048 Null 0.0171490505199913 0.01013211
NSC 697747 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(3-methoxyphenyl)- 0.0171490505199913 0.14061312
NSC 719502 Null 0.0171490505199913 -0.031517544
NSC 682866 Ethanone, 1-[7-(4-chlorophenyl)-5,6-dihydro-9-methyl- 7H-benzo[h]thiazolo[2,3-b]quinazolin-10-yl]- 0.0178844438004191 -0.0038689236
NSC 166237 Ethanol, 2,2'-[[3-methyl-4-[[[4-(2-methyl-4-thiazolyl)phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester), monohydrochloride (9CI) 0.0178844438004194 0.51618951
NSC 275656 m-Dioxane-5-methanol, 2,2-dimethyl-5-(4,6-diaziridinyl-2-S-triazinylamino)- 0.0178844438004194 0.70439282
NSC 381867 BAFILOMYCIN ANTIBIOTIC 0.0178844438004195 0.19170676
Total:53  Current:21    [First] [Prev] [Next] [Last]